Brand Name: CABLIVI Generic Name: (caplacizumab-yhdp). CABLIVI (caplacizumab-yhdp) is used to treat thrombotic thrombocytopenic purpura (aTTP) and thrombosis.
CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Brand Name: | CABLIVI |
Generic Name: | caplacizumab-yhdp |
Strength: | • For injection: 11 mg as a lyophilized powder in a single-dose vial. |
Manufacturer: | Ablynx US |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “CABLIVI (caplacizumab-yhdp)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for CABLIVI (caplacizumab-yhdp) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.